Signed in as:
filler@godaddy.com
The Microplate Dx RapidPlate Technology
After a ground-breaking pre-clinical study on the rapid antibiotic susceptibility testing of urinary tract infections, Microplate Dx achieved 96% accuracy to detect bacterial growth with a 30-minute time to result.
The rapid antibiotic susceptibility testing (AST) platform combines ground-breaking hardware with novel data processing algorithms to perform rapid antibiotic susceptibility testing of a patient's sample.
How It Works
Our Investors
Key Publications
2023
2023
2023
"Rapid assessment of antibiotic susceptibility using a fully 3D-printed impedance-based biosensor."
Roger Domingo-Roca, Perrine Lasserre, Lily Riordan, Alexander Macdonald, Alexandra Dobrea, Kate Duncan, Stuart Hannah, Michael Murphy, Paul Hoskisson, Damion Corrigan
Biosensors & Bioelectronics X, 2023, 13, 100308
2020
2023
2023
"Development of a Rapid, Antimicrobial Susceptibility Test for E. coli Based on Low-Cost, Screen-Printed Electrodes."
Stuart Hannah, Alexandra Dobrea, Perrine Lasserre, Ewen Blair, David Alcorn, Paul Hoskisson, Damion Corrigan
Biosensors 2020, 10(11), 153
2019
2023
2019
"Rapid antibiotic susceptibility testing using low-cost, commercially available screen-printed electrodes"
Stuart Hannah, Emily Addington, David Alcorn, Wenmiao Shu, Paul Hoskisson, Damion Corrigan
Biosensors & Bioelectronics 2019, 145, 111696
Copyright © 2022 Microplate Dx - All Rights Reserved.
Reg: SC706330.
VAT Number: 409 2248 07
Website Created by Charlton Morris